ML348 [Ligand Id: 13412] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL600764 (GNF-Pf-1127)
  • lysophospholipase 1/Acyl-protein thioesterase 1 in Human [ChEMBL: CHEMBL1681631] [GtoPdb: 3290] [UniProtKB: O75608]
There should be some charts here, you may need to enable JavaScript!
  • lysophospholipase 2/Acyl-protein thioesterase 2 in Human [ChEMBL: CHEMBL1932891] [GtoPdb: 3291] [UniProtKB: O95372]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
lysophospholipase 1/Acyl-protein thioesterase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1681631] [GtoPdb: 3290] [UniProtKB: O75608]
GtoPdb - - 6.52 pKi 300 nM Ki Medchemcomm (2014) 5: 268-276 [PMID:25558349]
ChEMBL Inhibition of APT1 (unknown origin) by FluPol-ABPP assay B 6.52 pKi 300 nM Ki Medchemcomm (2014) 5: 268-276 [PMID:25558349]
lysophospholipase 2/Acyl-protein thioesterase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1932891] [GtoPdb: 3291] [UniProtKB: O95372]
ChEMBL Inhibition of APT2 (unknown origin) by FluPol-ABPP assay B 5 pKi >10000 nM Ki Medchemcomm (2014) 5: 268-276 [PMID:25558349]
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364]
ChEMBL NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay F 5 pEC50 >10000 nM EC50 Proc Natl Acad Sci U S A (2008) 105: 9059-9064 [PMID:18579783]
ChEMBL NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay F 5.39 pEC50 4040 nM EC50 Proc Natl Acad Sci U S A (2008) 105: 9059-9064 [PMID:18579783]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]